The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumQuick Picks - ArQule Inc. (NASDAQ:ARQL), co-developer of the tivantinib cancer treatment, received word from its Japanese partner Kyowa Hakko Kirin Co., that Kyowa has suspended patient enrollment … Continue Reading
Read nowLong Ideas - Shares of Halozyme Therapeutics (NASDAQ:HALO) have recovered nicely since the stock was cut in half on news related to the company’s partnered products with Baxter … Continue Reading
Read nowShort Ideas - Discovery Laboratories (NASDAQ:DSCO) has moved up 28% on trading momentum following a Buy rating on the 24th. The company’s lead product, Surfaxin, was approved by … Continue Reading
Read nowQuick Picks - Cyberonics Inc. (NASDAQ:CYBX) today released Fiscal 1Q 2013 results that beat analyst expectations, sending shares up 10% in early trading, only to decline slightly into … Continue Reading
Read nowLong Ideas - Amarin Pharmaceuticals (NASDAQ:AMRN) could trade higher as investors digest this morning’s news that Roche’s (OTC:RHHBY) former Head of Global Pharmaceuticals has joined AstraZeneca (NYSE:AZN) as … Continue Reading
Read nowLong Ideas - Catalyst Pharmaceutical Partners (NASDAQ:CPRX) announced that in a direct public offering of 4 million shares of common stock and 1.2MM warrants, it will be raising … Continue Reading
Read now- Peregrine Pharmaceuticals (NASDAQ:PPHM) is becoming known among biotech traders for the company’s big swings and volatility. This morning’s 19% decline can be attributed to a … Continue Reading
Read now
